S Eissa

Summary

Publications

  1. Eissa S, Kenawy G, Swellam M, El Fadle A, Abd El Aal A, El Ahmady O. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin Biochem. 2004;37:803-10 pubmed
    ..However, when specificity was considered, CK-20 alone had superior sensitivity and specificity compared to ANG and voided urine cytology. ..
  2. Eissa S, Ahmed M, Said H, Zaghlool A, El Ahmady O. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. IUBMB Life. 2004;56:557-64 pubmed
    ..Cyclin D1 over-expression appears to be an early event in bladder cancer and might explain bilharzial associated bladder carcinogenesis. ..
  3. Eissa S, Ali Labib R, Swellam M, Bassiony M, Tash F, El Zayat T. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol. 2007;52:1388-96 pubmed
  4. Eissa S, Zohny S, Swellam M, Mahmoud M, El Zayat T, Salem A. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer. Clin Biochem. 2008;41:1335-41 pubmed publisher
    ..However, when the diagnostic efficacy was considered, CK20 mRNA by either conventional RT-PCR or real-time RT-PCR had the highest sensitivity and specificity compared to CD44 and VUC. ..
  5. Eissa S, Zohny S, Zekri A, El Zayat T, Maher A. Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence. Med Oncol. 2010;27:1286-94 pubmed publisher
    ..Mutant p53 is associated with disease recurrence and hence it has a significant prognostic role in bladder cancer. ..